The article presents abstracts on medical topics including the involvement of bone marrow in Hodgkin lymphoma, the metabolic response in interim positron emission tomography (PET) during Hodgkin lymphoma treatment, and the outcome of aggressive non-Hodgkin lymphoma patients with negative pretreatment PET scan.